JP Morgan Chase
BIOA

JP Morgan Chase’s BioAge Labs BIOA Stock Holding History

JP Morgan Chase’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.75M Buy
173,570
+151,541
+688% +$2.92M ﹤0.01% 3860
2025
Q4 		$291K Sell
22,029
-14,819
-40% -$131K ﹤0.01% 5330
2025
Q3 		$217K Buy
36,848
+25,638
+229% +$120K ﹤0.01% 5471
2025
Q2 		$46.3K Sell
11,210
-3,012
-21% -$12.1K ﹤0.01% 5954
2025
Q1 		$53.5K Buy
14,222
+8,887
+167% +$41.1K ﹤0.01% 5857
2024
Q4 		$30.9K Sell
5,335
-194,665
-97% -$3.36M ﹤0.01% 6148
2024
Q3 		$4.16M Buy
+200,000
New +$4.01M ﹤0.01% 3347

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

JP Morgan Chase's BIOA Position: Q1 2026 in Review

JP Morgan Chase increased its BioAge Labs (BIOA) stake by 688% in Q1 2026, buying an estimated $2.92M and bringing the position to 173,570 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3860.

JP Morgan Chase first reported a position in BIOA in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.16M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • JP Morgan Chase held 173,570 shares of BioAge Labs worth $2.75M as of Q1 2026.
  • JP Morgan Chase bought 151,541 BioAge Labs shares in Q1 2026, an estimated $2.92M.
  • BioAge Labs made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3860 holding.
  • JP Morgan Chase first reported a position in BioAge Labs in Q3 2024 and has held it in 7 quarters since.
  • JP Morgan Chase's BioAge Labs position peaked at $4.16M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.